Companies: 10,795·Total market cap: $144.5T
Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd.

KMTSNASDAQHealthcare● Active
$19.40
$-1.05(-5.13%)
Market Cap$1.1B
P/E Ratio
52W High$30
52W Low$13.25
Overview

Kestra Medical Technologies, Ltd. (KMTS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · KMTS · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.96kmts eps ttm · kmts earnings per shareEarnings history
PE Ratio (TTM)kmts pe ratio ttm · kmts price to earningsPE Ratio deep dive
Revenue (TTM)$83.7Mkmts revenue ttm · kmts annual revenueFull revenue history
Dividend YieldNo Dividenddoes kmts pay dividends · kmts dividend yieldDividend history
Shares Outstanding49.5Mkmts shares outstanding · kmts floatShares outstanding history
Next EarningsJul 21, 2026Est.kmts earnings date · kmts next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$59.8M▲ +115.05% YoY
202320242025
kestra medical technologies, ltd. revenue · kmts revenue 2025
FY 2025Net Income-$113.8M▼ 20.92% YoY
202320242025
kestra medical technologies, ltd. net income · kmts profit 2025
FY 2025EPS$-5.13▼ 151.47% YoY
202320242025
kmts eps · kestra medical technologies, ltd. earnings per share 2025
TTM:Revenue: $83.7MNet Income: -$144.8MEPS: $-3.96View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis kmts a buy · kmts analyst rating
Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$24.00Low
$19.40Current
$28.00Avg Target44.33% upside
$30.00High
kmts price target · kmts 12 month forecast

Total: 4 · Buy rate: 75.0%

The KMTS analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $28.00, representing +44.33% upside from the current price of $19.40.

Stock Performance

Full History
1D-5.13%
1W+4.08%
1M-7.84%
3M-15.80%
YTD-26.85%
1Y-8.36%
5Y-11.17%

About Kestra Medical Technologies, Ltd.

CEOBrian Webster
IPO DateMar 6, 2025
Employees300
CountryUS

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and thera…

what is kestra medical technologies, ltd. · kmts stock overview · kestra medical technologies, ltd. company profile · who is kestra medical technologies, ltd. ceo · kmts NASDAQ · kestra medical technologies, ltd. headquarters · kestra medical technologies, ltd. business segments

About Stock Overview & Key Data

Kestra Medical Technologies, Ltd. (KMTS) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Mar 6, 2025. As of the latest trading session, KMTS stock price is $19.40, with a market capitalization of $1.1B. The stock has returned -8.36% over the past 12 months and -26.85% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Kestra Medical Technologies, Ltd. stock is Buy, with an average 12-month price target of $28.00. In fiscal year 2025, Kestra Medical Technologies, Ltd. reported revenue of $59.8M and net income of -$113.8M. For detailed data — including Kestra Medical Technologies, Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Kestra Medical Technologies, Ltd. (KMTS) stock price is $19.40. The stock is traded on NASDAQ under the ticker symbol KMTS. The 52-week range is $13.25 – $30.00.

KMTS stock priceKMTS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice